Leucemia / linfoma de células T del adulto. Asociación con el virus HTLV1
Palabras clave:
eucemia/linfoma de células T del adulto, virus linfotrópico humano de células T de tipo 1, HTLV1, infomas cutáneos de células T, LLTAResumen
La leucemia/linfoma de células T del adulto (LLTA) es una neoplasia de linfocitos T maduros que se asocia al virus linfotrópico humano de células T de tipo 1 (HTLV1). Es muy agresiva, con una corta sobrevida en la mayoría de los casos y es resistente a la quimioterapia. No produce lesiones características en la piel, donde suele simular linfomas cutáneos de células T (LCCT) u otras dermatosis, y la afecta en el 43% a 72% de los casos. En la Argentina, en especial en la Ciudad Autónoma de Buenos Aires, debe considerarse una patología emergente debido a la mayor circulación del virus por la inmigración desde lugares endémicos.
Citas
I. Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, et ál. Adult T-ce-ll leukemia: clinical and hematologic features of 16 cases. Blood 1977;50:481-492.
II. Bittencourt AL, Paim de Oliveira M. Cutaneous manifes-tations associated with HTLV-1 infection. Int J Dermatol2010;49:1099-1110.
III. Cerrutti M. La migración peruana a la Ciudad de Buenos Ai-res: su evolución y características. Población de Buenos Aires. 2005. Vol 2. <https://www.researchgate.net/profile/Marce-la_Cerrutti/publication/242620392_La_migracion_perua-na_a_la_Ciudad_de_Buenos_Aires_su_evolucion_y_carac-tersticas/links/54ec4ef70cf27fbfd76f41c8.pdf> Consultado el 3 de marzo de 2016. ISSN 1668-5458.
IV. Gotuzzo E, Verdonck K, González E, Cabada M. Virus lin-fotrópico humano de células T tipo 1 (HTLV-1): una infec-ción endémica en el Perú. Rev Peru Med Exp Salud Pública2004;21:253-260.
V. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, et ál. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lym-phoma. P Natl Acad Sci USA 1980;70:7415-7419.
VI. Vásquez P. HTLV-1 (Human T-cell lymphotropic virus), algo que decir? Rev Chil Infect 2003;20:34-37.
VII. Biglione MM, Berini CA. Aportes y consideraciones sobre la infección por los virus linfotrópicos-T humanos tipo 1 y 2 en Argentina. Actual SIDA Infectol 2013;21:84-94.
VIII. Bangham CRM, Ratner L. How does HTLV-1 cause adult T-cell leukemia/lymphoma (ATL)? Curr Op Virol 2015;14:93-100.
IX. Kress AK, Grassman R, Fleckenstein B. Cell surface markers in HTLV-1 pathogenesis. Viruses 2011;3:1439-1459.
X. Tsuda T, Ishiwaka M, Banno T, Fujisawa S, et ál. A case of adult T-cell leukemia/lymphoma with an indolent clinical course has an unusual proviral DNA integration pattern. Acta Derm Venereol 2003;83:139-140.
XI. Tokura Y, Sawada Y, Shimauchi T. Skin manifestations of adult T-cell leukemia/lymphoma: Clinical, cytological and immu-nological features. J Dermatol 2014;41:19-25.
XII. Ishida T, Utsunoyima A, Iida S, Inagaki H, et ál. Clinical signi-ficance of CCR4 expression in adult T-cell leukemia/lympho-ma: its close association with skin involvement and unfavora-ble outcome. Clin Cancer Res 2003;9:3625-3634.
XIII. Sugita K, Shimauchi T, Kabashima R, Nakasshima D, et ál. Loss of CCR4 expression upon leukemic change in adult T-cell leu-kemia/lymphoma. J Am Acad Dermatol 2009;61:163-164.
XIV. Proietti FA, Carneiro-Proietti ABF, Catalan-Soares BC, Murphy EL. Global epidemiology of HTLV-1 infection and associated diseases. Oncogene 2005;24:6058-6068.
XV. Moreno C, Balangero M, Barbás MG, Cudolá A, et ál. Diagnós-tico serológico de HTLV-1/2: combinación de técnicas de ta-mizaje para definir estatus serológico en donantes de sangre. Rev Arg Microbiol 2013;45. http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0325-75412013000300006> Consultado el 3 de marzo de 2016; ISSN 0325-7541.
XVI. Gallego S, Mangano A, Gastaldello R, Sen L, et ál. Usefulness of a nested-polymerase chain reaction for molecular diag-nosis of human T-cell lymphotropic virus type I/II. Mem Inst Oswaldo Cruz 2004;99:377-380.
XVII. Ishikara K, Inokuchi N, Tsushima Y, Tsuruda K, et ál. Relevance of molecular tests for HTLV-1 infection as a confirmatory tests after the first sero-screening. J Immunoassay Immunochem2014;35:74-82.
XVIII. Yamaguchi T, Ohshima K, Karube K, Yutiya T, et ál. Clinicopa-thological features of cutaneous lesions of adult T-cell leuke-mia/lymphoma. Br J Dermatol 2005;152:76-81.
XIX. Gastaldello R, Hall WW, Gallego S. Seroepidemiology of HTLV-I/II in Argentina: an overview. J Acquir ImmuneDefic Sy-ndr 2004;35:301-308.
XX. Gessain A, Cassar O. Epidemiological aspects and world dis-tribution of HTLV-1 infection. Front Microbiol 2012;3:1-23.
XXI. Eirin M, Bravi C, Jones L, Berini C, et ál. Ethnic/geographic analy-sis of human T-cell lymphotropic virus type 1 (HTLV-1) infection among Buenos Aires residents in Argentina. Retrovir 2011;8:88.
XXII. Yazdanpanah MJ, Maleki M, Joneidi N, Khalighi AR, et ál. Cu-taneous manifestations in HTLV-1 positive blood donors. Iran J Basic Med Sci 2013;16:273-277.
XXIII. Sibon D, Cassar O, Duga I, Brouzes C, et ál. Adult T-cell leuke-mia/lymphoma in a Caucasian patient after sexual transmis-sion of human T-cell lymphotropic virus type 1. Open Forum Infect Dis 2015;2:1-5.
XIV. Shimoyama M. Diagnostic criteria and classification of clini-cal subtypes of adult T-cell leukaemia/lymphoma. Br J Hae-matol 1991;79:428-487.
XV. Marchetti MA, Pulitzer MP, Myskowski PL, Dusza SW, et ál. Cu-taneous manifestations of human T cell lymphotropic virus ty-pe-1-associated adult T-cell leukemia/lymphoma: A single-cen-ter retrospective study. J Am Acad Dermatol 2015;72:293-301.
XVI. Lucas CT, Gillisn K, Ness JM, Hammers YA, et ál. Adult T-cell leukemia/lymphoma in an adolescent presenting with skin lesions. Pediatr Dermatol 2008; 25:373-377.
XVII. Do Valle ACF, Galhardo MC, Leite ACC, Araújo AQC, et ál. Adult T-cell leukemia/lymphoma associated with HTLV-1 infection in a brazilian adolescent. Rev Inst Med trop S Paulo2001;43:283-286.
XVIII. Gioseffi ON, Nucifora E, Fanti D, Doufour C, et ál. Adult HTLV-1 positive leukemia-lymphoma in Argentina. Sangre 1995;40:421-424.
XIX. Prates V, Cobos M, Bouzas B, Napal J, et ál. The first report of familial adult T-cell leukemia/lymphoma in Argentina. Leuk Lymphoma 2000;37:225-227.
XXX. Marin O, Hasui K, Remondegui C, Sat E, et ál. Adult T-cell leu-kemia/lymphoma in Jujuy, north-west Argentina. Pathol Int2002;52: 348-357.
XXXI. Mangano A, Saliba Pineda M, Costantini P, Bouzas MB, et ál. HTLV-1 proviral load in adult T-cell leukemia/lymphoma (ATLL) patients from non-endemic regions of Argentina. Re-trovir 2014;11:34.
XXXII. Kaminsky A, Díaz M, Ryb M, Lagioia R, et ál. Virus de la leu-cemia T humana (HTLV-1). Linfoma/leucemia de células T del adulto. Presentación de un caso. Dermatol Argent 2003;9:295-300.
XXXIII. Forero O, Villoldo MS, Pastore F, Graciano S, et ál. Leucemia/linfoma de células T del adulto: HTLV-1 positivo. A propósito de un caso. Arch Argent Dermatol 2006;56:137-141.
XXXIV. Bittencourt AL, Vieira M, Brites CR, Farre L, et ál. Adult T-cell leu-kemia/lymphoma in Bahia, Brazil. Analysis of prognostic fac-tors in a group of 70 patients. Am J Clin Pathol 2007;128:875-882.
XXXV. Amano M, Kurokawa M, Ogta K, Itoh H, et ál. New entity, defi-nition and diagnostic criteria of cutaneous adult T-cell leuke-mia/lymphoma: Human T-lymphotropic virus type 1 proviral DNA load can distinguish between cutaneous and smolde-ring types. J Dermatol 2008;35:270-275.
XXXVI. Setoyama M, Katahira Y, Kanzaki T. Clinicopathologic analysis of 124 cases of adult T-cell leukemia/lymphoma with cuta-neous manifestations: the smouldering type with skin mani-festations has a poorer prognosis than previously thought. J Dermatol 1999;26:785-790.
XXXVII. Yagi H, Takigawa M, Hashizume H. Cutaneous type of adult T cell leukemia/lymphoma: a new entity among cutaneous lymphomas. J Dermatol 2003;30:641-643.
XXXVIII. Ocampo Lyra-da-Silva J, Mello Gonzaga YB, De Melo Espín-dola O, Andrada-Serpa MJ, et ál. Adult T-cell leukemia/lym-phoma: a case report of primary cutaneous tumoral type. Dermatol Pract Concept 2012;2:9-13.
XXXXIX. Chan H, Su I, Kuo T, Kuan Y, et ál. Cutaneous manifestations of adult T-cell leukemia/lymphoma. J Am AcadDermatol1985;13:213-219.
XL. Okada J, Imafuku S, Tsujita J, Moroi Y, et ál. Case of adult T-cell leukemia-lymphoma manifesting marked purpura. J Derma-tol 2007;34:782-785.
XLI. Pezeshkpoor F, Yazdanpanah MJ, Shirdel A. Specific cuta-neous manifestations in adult T-cell leukemia/lymphoma. Int J Dermatol 2008;47:359-362.
XLII. Sakamoto FH, Colleoni GWB, Teixeira SP, Yamamoto M, et ál.Cutaneous T-cell lymphoma with HTLV-1 infection: clinical overlap with adult T-cell leukemia/lymphoma. Int J Dermatol2006;45:447-449.
XLIII. Setoyama M, Yamamoto S, Kanzaki T. Adult T-cell leukemia/lymphoma presenting with digital gangrene. Dermatol 1997;195:150-152.
XLIV. Kawakami T, Kawanabe T, Soma Y. Granuloma annulare-like skin lesions as an initial manifestation in a Japanese patient with adult T-cell leukemia/lymphoma. J Am Acad Dermatol2009;60:848-852.
XLV. Shimizu S, Yasui C, Koizumi K, Ikeda H, et ál. Cutaneous-ty-pe adult T-cell leukemia/lymphoma presenting as a solitary skin nodule: A review of the literature. J Am Acad Dermatol2007;57:115-117.
XLVI. Bégon E, Blum L, Benramdane R, Leroux C, et ál. Oral mani-festation of Adult T-cell leukemia/lymphoma. Arch Dermatol 2010;146:804-805.
XLVII. Bittencourt AL, Barbosa HS, Vieira M, Farré L. Adult T-cell leu-kemia/lymphoma (ATL) presenting in the skin: clinical, histo-logical and immunohistochemical features of 52 cases. Acta Oncol 2009;48:598-604.
XLVIII. Brito Santos J, Farré L, Da Silva Batista E, Santos HH, et ál. The importance of flower cells for the early diagnosis of acute adult T-cell leukemia/lymphoma with skin involvement. Acta Oncol 2010;49:265-267.
XLIX. Othake N, Setoyama M, Fukumaru S, Kanzaki T. A case of adult T cell leukemia/lymphoma (ATLL) with angiocentric and angiodestructive features. J Dermatol 1997;24:165-169.
L. Camp B, Horwitz Y, Pulitzer M. Adult T-cell leukemia/lympho-ma with follicular mucinosis: an unusual histopathological finding and a commentary. J Cutan Pathol 2012;39:861-865.
LI. Ishida M, Iwai M, Yoshida K, Kagotani A, et ál. Adult T-cell leukemia/lymphoma accompanying follicular mucinosis: a case report with review of the literature. Int J Clin Exp Pathol2013;6:3014-3018.
LII. Setoyama M, Katahira Y, Kanzaki T, Kerdel, et ál. Adult T-cell leukemia/lymphoma with non infectious epithelioid granu-loma in the skin: a clinicopathologic study. Am J Dermopath1997;19:591-595.
LIII. Kim NH, Torchia D, Miteva M, Rongioletti F, et ál. Prominent apoptosis in Pautrier microabscesses: a distinctive finding in adult T-cell leukemia/lymphoma? Am J Dermatopath2011;33:530-531.
LIV. Karube K, Ohshima K, Tsuchiya T, Yamaguchi T, et ál. Expres-sion of FoxP3, a key molecule in CD4+CD25+ regulatory T cells, in adult T-cell leukemia/lymphoma cells. Br J Haematol 2004;126:81-84.
LV. Miyata T, Yonekura K, Utsunomiya A, Kanekura T, et ál. Cu-taneous Adult T-cell leukemia/lymphoma is a characteristic subtype and includes erythema/papule and nodule/tumor subgroups. Int J Cancer 2010;126:1521-1528.
LVI. Tsukasaki K, Hermine O, Bazarbachi A, Ratner L, et ál. Defini-tion, prognostic factors, treatment and response criteria of adult T-cell leukemia-lymphoma: a proposal from an interna-tional consensus meeting. J Clin Oncol 2009;27:453-459.
LVII. Kawai K, Uchida Y, Yonekura K, Virtanen S, et ál. Cutaneous-ty-pe adult T-cell leukemia/lymphoma does not primarily show deletion of NAV3 gene. J Invest Dermatol 2010;130:316-318.
LVIII. Bazarbachi A, Plumelle Y, Ramos JC, Tortevoye P, et ál. Me-ta-analysis of the use of zidovudine and interferon-alfa in in adult T-cell leukemia/lymphoma showing improved survival in leukemic types. J Clin Oncol 2010;28:4177-4183.
LIX. Sawada Y, Hino R, Hama K, Ohmori S, et ál. Type of skin erup-tion is an independent prognostic indicator for adult T-cell leu-kemia/lymphoma. Blood 2011;117:3961-3967.
LX. Olivares L, D ́Atri G, Martinetti C, Ciccia L, et ál. Dermatitis infectiva asociada a HTLV-1, en un adulto. Dermatol Argent2009;15:49-53.
LXI. Díaz CJ, Valencia M. Manifestaciones cutáneas asociadas con el HTLV-1. Rev Asoc Colomb Dermatol 2011;22:67-73.
LXII. Uozumi K. Treatment of adult T-cell leukemia. J Clin Exp Hae-matopathol 2010;50:9-25.
LXIII. Tsukasaki K, Utsunoyima A, Fukuda H, Shibata T, et ál. VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801. J Clin Oncol. 2007; 25: 5458-5464.
LXIV. Hermine O, Bouscary D, Gessain A, Turlure V, et ál. Brief report: treatment of Adult T-cell leukemia/lymphoma with zidovudi-ne and interferon alfa. N Engl J Med 1995;332:1749-1751.
LXV. Takemori N, Hirai K, Onoderea R, Saito N, et ál. Satisfactory remis-sion achieved by PUVA therapy in a case of crisis-type adult T-ce-ll leukemia/lymphoma with generalized cutaneous leukaemic cell infiltration. Br J Dermatol 1995;133:955-960(Abstract).
LXVI. Itonaga H, Tsushima JT, Fukushima T, Taniguchi H, et ál. Treat-ment of relapsed adult T-cell leukemia/lymphoma after allo-geneic hematopoietic stem cell transplantation: the Nagasaki Transplant Group experience. Blood 2013;121:219-225.
LXVII. Ishida T, Joh T, Uike N, Yamamoto K, et ál. Defucosylated an-ti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia/lymphoma: a multicenter phase II study. J Clin Oncol 2012;30:837-842.
LXVIII. Idhida T, Jo T, Takemoto S, Suzushima H, et ál. Dose-intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lympho-ma: a randomized phase II study. Br J Dermatol 2015;169:672-682.
LXIX. Waldmann TA, White JD, Goldman CK, Top L, et ál. The interleu-kin-2 receptor: a target for monoclonal antibody treatment of human T-cell lymphotropic virus 1- induced adult T-cell leuke-mia. Blood 1993;82:1701-1712.
LXX. Richardson S, Budgin JB, Junkins-Hopkins JM, Vittorio CC, et ál. Low-dose bexaroteno and low-dose interferon alfa-2b for in adult T-cell leukemia/lymphoma associated with human T-lymphotropic virus 1. Arch Dermatol 2005;141:301-304.
LXXI. Plumelle Y, Michel S, Banydeen R, Delaunay C, et ál. Characte-ristics of adult T-cell leukemia-lymphoma patients with long survival: prognostic significance of skin lesions and possible beneficial role of valproic acid. Leuk Res Treatment 2015. Vol 2015. < http://www.hindawi.com/journals/lrt/2015/476805/> Consultado el 13 de diciembre de 2015; ISSN 2090-3219
LXXII. Ishitzuka K, Utsunomiya A, Katsuya H, Takeuchi S, et ál. A pha-se II study of bortezomib in patients with relapsed or refrac-tory aggressive adult T-cell leukemia/lymphoma. Cancer Sci2015;106:1219-1223.
LXXIII. Simone CB, Morris JC, Stewart DM, Urquhart NE, et ál. Radiation therapy for management of patients with HTLV-1 associated adult T-cell leukemia/lymphoma. Blood 2012;120:1816-1819.
Descargas
Publicado
Número
Sección
Licencia
Derechos de autor 2017 Sociedad Argentina de Dermatología
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.
El/los autor/es tranfieren todos los derechos de autor del manuscrito arriba mencionado a Dermatología Argentina en el caso de que el trabajo sea publicado. El/los autor/es declaran que el artículo es original, que no infringe ningún derecho de propiedad intelectual u otros derechos de terceros, que no se encuentra bajo consideración de otra revista y que no ha sido previamente publicado.
Le solicitamos haga click aquí para imprimir, firmar y enviar por correo postal la transferencia de los derechos de autor
